Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION
| Report ID | 148580 |
| Drug Identification Number | 02314932 |
| Brand name | LEVOFLOXACIN IN 5% DEXTROSE INJECTION |
| Common or Proper name | LEVOFLOXACIN IN 5% DEXTROSE INJECTION |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVOFLOXACIN |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 24 x 50 mL bag |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-04-06 |
| Estimated end date | |
| Actual end date | 2022-10-26 |
| Shortage status | Resolved |
| Updated date | 2023-01-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.